Ebitda for the pharma major rose 27.5% on-year from ₹1,146 crore in Q2FY24 to ₹1,461 crore in the September quarter this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback